This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Epidural haemorrhage
ST19_EPIDU_HAEMORRHAGE
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
369 |
4. Check minimum number of eventsNone |
369 |
5. Include endpointsNone |
369 |
6. Filter based on genotype QC (FinnGen only) |
369 |
Control definitions (FinnGen only)
- Control exclude
- NEURODIS
Extra metadata
- Level in the ICD hierarchy
- 4
- Special
- ST19_EDHTRAU
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- S06
- Name in latin
- Haemorrhagia epiduralis traumatica
Similar endpoints
↥List of similar endpoints to
Epidural haemorrhage
based on the number of shared cases.
Similar with more cases:
- severe traumatic brain injury, does not include concussion
- Intracranial trauma
- Bleeding
- Neurological diseases, wide definition
- Injury, poisoning and certain other consequences of external causes
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 369 | 108 | 261 |
| Unadjusted period prevalence (%) | 0.09 | 0.04 | 0.12 |
| Median age at first event (years) | 48.10 | 48.51 | 47.93 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 339
- Matched controls
- 3389
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
S06.4
ICD-10 Finland
Epidural haemorrhage
+∞
323.0
282
*
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
+∞
148.0
131
*
AA1AD
NOMESCO Finland
CT of head and brain
20.7
101.9
165
148
S06.3
ICD-10 Finland
Focal brain injury
1125.2
91.2
85
*
T90.5
ICD-10 Finland
Sequelae of intracranial injury
1055.5
86.6
81
*
AAD00
NOMESCO Finland
Evacuation of epidural haematoma
+∞
81.6
75
*
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
8.6
67.6
190
439
S06.0
ICD-10 Finland
Concussion
52.6
57.4
68
16
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
+∞
55.8
52
*
S06.2
ICD-10 Finland
Diffuse brain injury
+∞
54.7
51
*
S06.6
ICD-10 Finland
Traumatic subarachnoid haemorrhage
+∞
42.6
40
*
W19
ICD-10 Finland
Unspecified fall
11.7
42.0
82
90
R56.8
ICD-10 Finland
Other and unspecified convulsions
21.6
39.1
58
32
2211
FHL
Hematoma removal, epidural
+∞
36.1
34
*
X59
ICD-10 Finland
Exposure to unspecified factor
5.9
35.7
116
275
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
6.3
32.8
98
206
S02.11
ICD-10 Finland
Fracture of base of skull, open
355.3
32.4
32
*
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
9.3
32.4
71
94
G40.9
ICD-10 Finland
Epilepsy, unspecified
+∞
31.8
30
*
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
7.5
31.5
80
134
S02.00
ICD-10 Finland
Fracture of the upper part of the head closed
342.6
31.4
31
*
NA1AD
NOMESCO Finland
Cervical spine CT examination
20.3
30.6
46
26
XA800
NOMESCO Finland
Neuropsychological investigation
31.2
29.6
39
14
AAD10
NOMESCO Finland
Evacuation of chronic subdural haematoma
+∞
29.6
28
*
S02.10
ICD-10 Finland
Fracture of base of skull, closed
113.3
29.2
31
*
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
305.1
28.2
28
*
N03AX14
ATC
levetiracetam; systemic
109.3
28.1
30
*
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
+∞
27.5
26
*
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
13.5
24.0
42
35
G47.3
ICD-10 Finland
Sleep apnoea
14.5
23.1
39
30
N03AF01
ATC
carbamazepine; oral, rectal
16.4
23.1
37
25
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
4.7
22.3
85
227
N03AF02
ATC
oxcarbazepine; oral
122.9
21.8
23
*
N03AG01
ATC
valproic acid; systemic, rectal
12.1
21.3
39
36
W10
ICD-10 Finland
Fall on and from stairs and steps
10.9
21.3
41
42
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
222.9
20.8
21
*
K90
ICPC
Stroke/cerebrovascular accident
+∞
20.0
19
*
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
+∞
20.0
19
*
AAA27
NOMESCO Finland
Insertion of intracerebral pressure monitoring device
+∞
18.9
18
*
N03AB02
ATC
phenytoin; systemic
+∞
18.9
18
*
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
200.5
18.7
19
*
S01.0
ICD-10 Finland
Open wound of scalp
6.0
16.8
48
91
AAD05
NOMESCO Finland
Evacuation of acute subdural haematoma
+∞
16.8
16
*
X58
ICD-10 Finland
Exposure to other specified factors
4.0
16.3
72
216
8524A
ICD-9 Finland
Subarachnoid, subdural and extradural haemorrhage, following injury, Extradural haemorrhage following injury without mention of open intracranial wound[HAEMORRHAGIA EPIDURALIS TR ,EI TIETOA TAJUTTOMUUDES]
+∞
15.7
15
*
8524B
ICD-9 Finland
Subarachnoid, subdural and extradural haemorrhage, following injury, Extradural haemorrhage following injury without mention of open intracranial wound[HAEMORRHAGIA EPIDURALIS TRAUMATICA,EI TAJUTTOMUUTTA]
+∞
15.7
15
*
F10.25
ICD-10 Finland
Alcohol dependence continuous use
23.4
15.7
22
10
F10.24
ICD-10 Finland
Alcohol depence active use
21.1
13.9
20
10
F10.29
ICD-10 Finland
Addiction caused by alcohol UNS
10.0
13.7
27
29
W17
ICD-10 Finland
Other fall from one level to another
7.6
13.7
32
46
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
+∞
13.6
13
*
I60.9
ICD-10 Finland
Subarachnoid haemorrhage, unspecified
+∞
13.6
13
*
F10.20
ICD-10 Finland
Alcohol dependence currently independent
12.2
13.5
24
21
F10.09
ICD-10 Finland
Alcohol intoxication UNS
15.9
13.3
21
14
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
41.8
13.3
16
*
E882A
ICD-9 Finland
Fall from or out of building or other structure
17.6
13.1
20
12
G40
ICD-10 Finland
Epilepsy
+∞
12.6
12
*
JN5BD
NOMESCO Finland
Head and body CT examination for trauma
48.4
12.0
14
*
P15
ICPC
Chronic alcohol abuse
9.5
12.0
24
27
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
6.3
11.8
31
53
F05.9
ICD-10 Finland
Delirium, unspecified
23.9
11.7
16
7
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
6.8
11.7
29
46
T36
ICD-10 Finland
Poisoning by systemic antibiotics
7.9
11.7
26
35
S06.9
ICD-10 Finland
Intracranial injury, unspecified
+∞
11.5
11
*
AAF00
NOMESCO Finland
Ventriculostomy
123.9
11.5
12
*
N05AH04
ATC
quetiapine; oral
3.5
11.4
56
182
R4120
NOMESCO Finland
Occupational therapy
6.5
11.3
29
48
A28
ICPC
Limited function/disability NOS
3.9
11.2
47
134
N02BE01
ATC
paracetamol; systemic, rectal
2.4
11.1
269
2069
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
6.0
10.7
29
52
F10.00
ICD-10 Finland
Alcohol-related acute intoxication uncomplicated
11.8
10.7
19
17
S22.4
ICD-10 Finland
Multiple fractures of ribs
10.5
10.7
20
20
N05CF01
ATC
zopiclone; oral
2.4
10.6
102
507
S02.01
ICD-10 Finland
Fracture of the upper part of the head open
+∞
10.5
10
*
N06AX11
ATC
mirtazapine; oral
2.5
10.5
95
456
R51.80
ICD-10 Finland
Headache
3.9
10.2
43
123
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.3
10.0
53
182
N05BA01
ATC
diazepam; systemic, rectal
3.3
10.0
51
171
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
17.3
10.0
15
9
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.5
9.9
86
402
V19
ICD-10 Finland
Pedal cyclist injured in other and unspecified transport accidents
10.0
9.9
19
20
S42.0
ICD-10 Finland
Fracture of clavicle
7.8
9.9
22
30
3039X
ICD-9 Finland
Alcohol dependence syndrome, Other and unspecified alcohol dependence
13.9
9.8
16
12
WX730
NOMESCO Finland
Conventional respirator
11.9
9.7
17
15
F10.31
ICD-10 Finland
Withdrawal symptoms caused by alcohol with seizures
22.4
9.4
13
6
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
+∞
9.4
9
*
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
+∞
9.4
9
*
G44.2
ICD-10 Finland
Tension-type headache
4.5
9.4
33
80
F10.26
ICD-10 Finland
Alcohol dependence periodic alcoholism
10.5
9.1
17
17
N29
ICPC
Neurological sympt/complt other
24.8
9.0
12
5
N05AH03
ATC
olanzapine; systemic
4.5
8.6
30
72
V49.9
ICD-10 Finland
Car occupant [any] injured in unspecified traffic accident
6.7
8.6
21
33
F10.39
ICD-10 Finland
Withdrawal symptoms caused by alcohol UNS
16.8
8.6
13
8
SPAT1215
SPAT
Assessment of need for medical rehabilitation
7.7
8.6
19
26
N02AX02
ATC
tramadol; systemic, rectal
2.1
8.5
128
767
F32.9
ICD-10 Finland
Depressive episode, unspecified
3.4
8.5
41
132
G31.2
ICD-10 Finland
Degeneration of nervous system due to alcohol
92.2
8.4
9
*
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
92.2
8.4
9
*
AAC00
NOMESCO Finland
Ligature of intracranial aneurysm
+∞
8.4
8
*
G41.9
ICD-10 Finland
Status epilepticus, unspecified
+∞
8.4
8
*
AAK00
NOMESCO Finland
Cranioplasty
+∞
8.4
8
*
F10.30
ICD-10 Finland
Withdrawal symptoms caused by alcohol uncomplicated
14.9
8.3
13
9
N07BB01
ATC
disulfiram; oral
4.5
8.2
28
66
W00
ICD-10 Finland
Fall on same level involving ice and snow
3.4
8.2
39
124
R41.0
ICD-10 Finland
Disorientation, unspecified
12.1
8.1
14
12
S02.40
ICD-10 Finland
Fracture of malar and maxillary bones, closed
9.3
8.1
16
18
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
9.3
8.1
16
18
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
22.6
8.1
11
5
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
13.4
7.9
13
10
AA3AD
NOMESCO Finland
CT of face
46.0
7.7
9
*
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.8
7.7
32
91
N06AB10
ATC
escitalopram; oral
2.6
7.7
60
262
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
6.0
7.6
20
35
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
4.1
7.6
28
72
N03AX12
ATC
gabapentin; oral
3.1
7.6
40
138
N06AB04
ATC
citalopram; systemic
2.5
7.5
60
266
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
5.5
7.5
21
40
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
5.5
7.5
21
40
I69.0
ICD-10 Finland
Sequelae of subarachnoid haemorrhage
81.7
7.4
8
*
Y96.9
ICD-10 Finland
Unspecified type of accident
13.8
7.4
12
9
F10.2
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Dependence syndrome
13.8
7.4
12
9
R53
ICD-10 Finland
Malaise and fatigue
2.6
7.4
56
241
N03AX18
ATC
lacosamide; systemic
+∞
7.3
7
*
183
Kela drug reimbursment
Lamotrigin and topiramate
+∞
7.3
7
*
85000
ICD-8 Finland
Concussion, Current or unspecified
+∞
7.3
7
*
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
+∞
7.3
7
*
G72.8
ICD-10 Finland
Other specified myopathies
+∞
7.3
7
*
S22.3
ICD-10 Finland
Fracture of rib
3.8
7.3
30
85
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
16.2
7.3
11
7
JN4BD
NOMESCO Finland
Extensive body CT
2.9
7.2
43
161
V14.9
ICD-10 Finland
Pedal cyclist injured in collision with heavy transport vehicle or bus, unspecified pedal cyclist injured in traffic accident
30.7
7.2
9
*
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
5.9
7.2
19
34
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
7.2
7.1
16
23
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
7.0
121
753
EBA00
NOMESCO Finland
Extraction of tooth
2.0
6.9
108
644
F29
ICD-10 Finland
Unspecified nonorganic psychosis
4.7
6.9
22
49
N80
ICPC
Head injury other
11.2
6.8
12
11
R5140
NOMESCO Finland
Monitoring the use of the aid
4.9
6.8
21
45
N18
ICPC
Paralysis/weakness
40.9
6.8
8
*
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
40.9
6.8
8
*
G57.3
ICD-10 Finland
Lesion of lateral popliteal nerve
40.9
6.8
8
*
N03AX11
ATC
topiramate; oral
17.1
6.8
10
6
N06AX16
ATC
venlafaxine; oral
2.9
6.7
39
144
Z46.8
ICD-10 Finland
Fitting and adjustment of other specified devices
9.0
6.6
13
15
GBB00
NOMESCO Finland
Tracheostomy
10.3
6.6
12
12
N05CD07
ATC
temazepam; oral
2.8
6.6
41
156
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.0
6.6
96
559
S42.2
ICD-10 Finland
Fracture of upper end of humerus
5.5
6.6
18
34
NE1AA
NOMESCO Finland
Pelvis X-ray examination
4.2
6.5
23
57
SPAT1301
SPAT
No procedures
2.0
6.5
91
521
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
3.8
6.4
26
73
V14.2
ICD-10 Finland
Pedal cyclist injured in collision with heavy transport vehicle or bus, unspecified pedal cyclist injured in nontraffic accident
71.1
6.4
7
*
E801E
ICD-9 Finland
Railway accident involving collision with other object[MOOTTORIK AJON AIH TAPAT YL LIIKAL,POLKUPYÖR/KULJET]
71.1
6.4
7
*
PA2AD
NOMESCO Finland
CT angiography of brain
71.1
6.4
7
*
Y07
ICD-10 Finland
Other maltreatment
14.7
6.4
10
7
Z72.1
ICD-10 Finland
Alcohol use
8.4
6.4
13
16
G30.1
ICD-10 Finland
Alzheimer disease with late onset
11.3
6.3
11
10
A06AD11
ATC
lactulose; oral
2.7
6.3
43
172
F10.49
ICD-10 Finland
Withdrawal symptoms and delirium caused by alcohol without information about seizures
18.4
6.3
9
5
F07.2
ICD-10 Finland
Postconcussional syndrome
+∞
6.3
6
*
G81.9
ICD-10 Finland
Hemiplegia, unspecified
+∞
6.3
6
*
8524C
ICD-9 Finland
Subarachnoid, subdural and extradural haemorrhage, following injury, Extradural haemorrhage following injury without mention of open intracranial wound[HAEMORRHAGIA EPIDURALIS TR,ALLE TUNNIN TAJUTTOMUUS]
+∞
6.3
6
*
8524D
ICD-9 Finland
Subarachnoid, subdural and extradural haemorrhage, following injury, Extradural haemorrhage following injury without mention of open intracranial wound[HAEMORRHAGIA EPIDURALIS TR,1-24 TUNTIA TAJUTTOMUUS]
+∞
6.3
6
*
N05BA09
ATC
clobazam; oral
+∞
6.3
6
*
F10.01
ICD-10 Finland
Alcohol-related acute intoxication with permanent or other somatic damage
+∞
6.3
6
*
S06.1
ICD-10 Finland
Traumatic cerebral oedema
+∞
6.3
6
*
I62.0
ICD-10 Finland
Nontraumatic subdural haemorrhage
+∞
6.3
6
*
G40.89
ICD-10 Finland
Other epilepsy
+∞
6.3
6
*
Z01.8
ICD-10 Finland
Other specified special examinations
2.3
6.3
61
298
N28
ICPC
Limited function/disability (N)
27.2
6.3
8
*
S02.70
ICD-10 Finland
Multiple fractures involving skull and facial bones, closed
27.2
6.3
8
*
N03AX16
ATC
pregabalin; oral
2.3
6.2
57
272
WX408
NOMESCO Finland
General anesthesy, balanced
2.1
6.2
80
442
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
4.3
6.1
21
51
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
8.8
6.1
12
14
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
8.8
6.1
12
14
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.4
6.1
53
245
U04
ICPC
Incontinence urine
6.2
6.1
15
25
S32.0
ICD-10 Finland
Fracture of lumbar vertebra
6.2
6.1
15
25
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
141
524
3.74
31.45
3.4
1.8
u/l
269.2
231.0
0.18
135
483
(3023183) Ammonium ion [Moles/volume] in Plasma
29
31
10.07
24.73
1.7
2.9
umol/l
30.7
34.2
0.38
24
25
(3003396) Base excess in Arterial blood by calculation
75
238
3.70
20.36
10.6
8.8
mmol/l
2.5
0.8
2.65
58
187
(3020779) Urea [Moles/volume] in Serum or Plasma
60
171
4.00
18.94
2.5
7.0
mmol/l
7.3
9.3
1.38
55
160
(3018677) aPTT in Platelet poor plasma by Coagulation assay
76
285
3.10
15.57
1.7
2.5
s
29.2
29.9
0.60
76
277
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
170
975
2.38
14.68
8.0
6.5
mmol/l
1.2
1.2
3.90
162
889
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
184
1093
2.36
14.64
8.2
7.1
mmol/l
1.2
1.2
2.47
163
928
(3012095) Magnesium [Moles/volume] in Serum or Plasma
85
352
2.84
14.51
2.8
3.8
mmol/l
0.8
0.8
0.16
78
334
(3024561) Albumin [Mass/volume] in Serum or Plasma
168
963
2.37
14.47
4.2
5.2
g/l
34.4
35.9
2.30
156
892
(3019060) Gas panel - Arterial blood
45
127
3.90
14.29
8.8
4.7
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
159
896
2.36
14.18
7.4
7.8
inr
1.2
1.2
0.02
43
262
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
196
1249
2.21
12.58
5.3
6.9
umol/l
11.4
12.4
0.51
185
1189
(3023368) Bacteria identified in Blood by Culture
117
604
2.37
12.47
4.7
4.3
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
16
21
7.92
11.51
2.9
2.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
65
269
2.72
10.93
22.0
21.9
inr
1.1
1.4
—
9
41
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
144
850
2.14
10.82
4.3
3.0
ng/l
35.1
68.7
1.12
113
571
(3019309) Folate [Moles/volume] in Red Blood Cells
77
350
2.52
10.70
1.7
1.7
nmol/l
1107.7
1198.0
0.39
60
271
(3011288) Drugs identified in Urine by Screen method
30
78
4.10
10.61
4.7
3.1
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
207
1409
2.07
10.52
8.0
4.5
mmol/l
6.7
6.6
0.06
201
1304
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
12
12
10.30
10.49
1.3
1.7
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
14
7
20.71
9.87
2.9
1.0
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
26
65
4.23
9.68
6.1
4.7
mmol/l
1.4
1.4
0.01
26
65
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
75
353
2.41
9.60
1.8
1.8
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
139
841
2.05
9.54
3.8
3.5
u/l
41.5
32.9
1.48
133
801
(3026008) Bacteria identified in Urine by Culture
101
554
2.13
8.92
3.0
2.6
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
55
237
2.55
8.46
1.9
1.8
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
137
858
1.95
8.29
2.1
1.8
pmol/l
94.5
94.2
0.02
84
450
(3021960) Folate [Moles/volume] in Serum or Plasma
85
456
2.12
7.85
1.5
1.4
nmol/l
19.7
19.8
0.02
76
391
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
36
131
2.94
7.63
1.7
1.6
—
—
—
0
0
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
54
244
2.42
7.49
1.9
1.8
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
28
90
3.28
7.30
2.6
2.8
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
67
338
2.20
7.19
1.9
2.0
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
119
742
1.89
7.11
2.5
2.5
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
73
384
2.12
7.05
3.1
1.7
%
2.2
1.4
4.70
62
349
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
131
850
1.84
6.86
2.7
2.8
—
—
—
0
0
(3016293) Bicarbonate [Moles/volume] in Serum or Plasma
36
139
2.76
6.86
8.7
10.4
mmol/l
25.0
24.5
0.28
36
139
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
233
1795
1.81
6.83
3.4
3.2
pmol/l
14.8
14.8
0.04
205
1602
(3028707) Methadone [Presence] in Urine by Screen method
19
49
4.03
6.79
2.9
4.1
—
—
—
0
0
(3020891) Body temperature
24
74
3.40
6.68
7.4
4.2
—
—
—
0
0
(3012544) pH of Venous blood
46
204
2.43
6.63
2.7
4.8
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
119
757
1.84
6.60
3.3
2.4
u/l
60.3
57.4
0.24
111
702
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
34
133
2.71
6.32
13.5
11.2
%
1.9
1.2
1.35
34
133
(1761868) Lipid panel - Serum or Plasma
66
1127
0.50
6.31
2.5
2.5
—
—
—
0
0
(3018418) pH of Serum or Plasma
102
630
1.86
6.16
2.6
3.9
ph
7.4
7.4
0.36
17
120
(3008295) Osmolality of Serum or Plasma
11
19
5.94
6.14
1.5
2.1
mosm/kgh2o
259.0
283.7
—
5
11
(3002032) Base excess in Venous blood by calculation
44
199
2.38
6.08
2.8
4.8
mmol/l
1.6
1.6
0.03
39
153
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
246
1963
1.76
6.01
6.9
7.4
u/l
84.1
79.4
0.61
228
1829
(36304419) Bacteria [Presence] in Urine
100
625
1.82
5.77
2.8
2.7
—
—
—
0
0
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
33
135
2.59
5.63
13.8
11.1
%
0.8
0.6
1.19
33
135
(3007930) Methemoglobin/Hemoglobin.total in Blood
25
91
2.87
5.32
10.9
5.5
%
2.1
0.9
0.54
25
86
(3016018) Differential panel - Cerebral spinal fluid
9
8
11.49
5.31
3.3
3.0
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
5
0
+∞
5.22
1.0
0.0
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
109
718
1.74
5.20
2.5
3.3
mmol/l
2.3
2.4
0.73
90
628
(3016879) Cocaine [Presence] in Urine
28
112
2.62
5.01
3.6
2.8
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
155
1136
1.63
4.87
4.4
4.0
—
—
—
0
0
(3000991) Gas panel - Venous blood
39
185
2.24
4.84
10.3
9.9
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
79
483
1.81
4.83
2.3
2.3
e6/l
5.2
4.4
0.21
66
422
(3002582) Erythrocytes [#/volume] in Urine
107
717
1.69
4.74
3.0
2.8
e6/l
17.8
54.5
1.91
78
543
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
38
180
2.24
4.73
2.8
2.4
ug/l
5.0
7.8
0.77
31
160
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
89
568
1.75
4.70
2.7
2.5
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
69
408
1.85
4.69
5.8
3.2
ng/l
99.6
803.8
1.94
56
331
(3026782) Osmolality of Urine
75
456
1.81
4.66
2.4
2.6
mosm/kgh2o
562.9
581.3
0.25
56
385
(3018095) Leukocytes [#/volume] in Urine
120
834
1.65
4.61
3.4
3.3
e6/l
97.3
191.5
0.48
83
585
(3012501) Base excess in Blood by calculation
14
39
3.69
4.53
3.2
5.2
mmol/l
4.2
2.0
—
9
25
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
28
119
2.46
4.44
14.6
11.0
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
36
172
2.21
4.40
2.8
4.6
kpa
4.5
4.4
0.14
36
165
(3000764) Benzodiazepines [Presence] in Urine
29
126
2.41
4.39
3.6
2.6
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
16
50
3.30
4.39
1.5
1.4
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
14
40
3.60
4.37
3.2
5.3
kpa
5.2
4.9
0.57
14
40
(3027315) Oxygen [Partial pressure] in Blood
14
40
3.60
4.37
3.2
5.3
kpa
8.9
8.4
0.47
14
40
(3027008) Opiates [Presence] in Urine
29
127
2.39
4.32
3.5
2.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
29
128
2.37
4.25
3.5
2.6
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
43
224
2.04
4.23
2.8
2.4
u/l
1495.1
49.5
0.49
28
197
(3023410) Appearance of Cerebral spinal fluid
9
13
7.07
4.18
3.2
2.9
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
115
816
1.59
3.98
5.8
6.2
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
18
65
2.86
3.91
2.0
1.7
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
267
2292
1.60
3.89
4.3
3.7
mu/l
1.8
1.9
1.09
246
2052
(3030467) Casts [#/volume] in Urine by Automated count
95
655
1.61
3.67
2.9
2.8
e6/l
1.0
0.4
0.72
69
484
(3019225) pH of Specimen
39
207
1.99
3.65
4.6
4.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
12
35
3.51
3.65
2.3
3.5
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
45
254
1.88
3.53
5.4
3.0
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
78
517
1.65
3.52
3.2
3.2
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
22
94
2.43
3.48
2.3
3.6
%
2.0
1.3
1.57
22
94
(3037467) Urinalysis macro (dipstick) panel - Urine
210
1736
1.49
3.43
4.2
3.4
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
46
266
1.83
3.35
1.9
1.6
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
32
164
2.04
3.31
1.6
1.5
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
13
43
3.10
3.28
1.2
1.2
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
13
43
3.10
3.28
1.2
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
35
186
1.97
3.28
2.7
3.0
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
40
224
1.88
3.22
2.5
3.0
g/l
0.2
0.2
1.08
33
210
(3027944) Amphetamines [Presence] in Urine
26
125
2.16
3.17
3.7
2.7
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
6
8
7.60
3.06
1.0
1.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
28
142
2.05
2.99
1.8
1.3
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
221
1875
1.45
2.97
4.7
2.8
u/l
77.3
50.9
2.03
206
1748
(3019550) Sodium [Moles/volume] in Serum or Plasma
310
2826
1.61
2.83
23.7
12.8
mmol/l
138.6
139.7
6.63
301
2736
(3013650) Neutrophils [#/volume] in Blood by Automated count
178
1462
1.42
2.80
8.6
10.4
e9/l
4.5
4.1
0.96
151
1272
(3007566) Smooth muscle Ab [Titer] in Serum
17
72
2.43
2.77
1.1
1.3
—
58.0
—
0
5
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
257
2841
0.69
2.71
4.0
3.9
mmol/l
4.6
4.7
0.79
240
2634
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
75
524
1.54
2.69
2.5
2.2
mg/l
2.9
2.9
0.02
64
450
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
8
19
4.28
2.69
1.4
1.4
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
120
927
1.44
2.62
1.9
2.2
nmol/l
68.3
76.3
2.24
110
834
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
44
271
1.71
2.62
2.2
2.8
umol/l
8.4
7.8
0.15
35
241
(3023103) Potassium [Moles/volume] in Serum or Plasma
310
2840
1.57
2.61
23.3
12.9
mmol/l
4.0
4.0
1.03
301
2745
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
255
2817
0.69
2.61
3.9
3.8
mmol/l
1.4
1.4
0.43
237
2604
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
6
11
5.52
2.55
2.8
1.8
nmol/l
17.3
20.0
—
6
11
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
14
57
2.51
2.48
1.0
1.4
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
246
2727
0.71
2.47
3.6
3.5
mmol/l
1.5
1.3
1.45
228
2513
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
6
12
5.06
2.41
1.2
1.0
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
6
12
5.06
2.41
1.2
1.0
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
212
1824
1.38
2.41
3.9
3.6
mm/h
14.3
11.3
1.33
200
1655
(3034770) Mitochondria Ab [Titer] in Serum
16
71
2.31
2.38
1.1
1.3
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
21
105
2.06
2.36
4.8
6.2
mmol/l
2.6
2.2
0.14
15
82
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
17
334
0.49
2.29
1.7
1.6
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
46
300
1.61
2.22
1.3
1.2
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
5
9
5.61
2.22
1.2
1.0
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
120
952
1.39
2.20
2.7
2.6
ug/l
142.0
183.1
1.26
109
886
(21494755) Public health laboratory ask at order entry panel
18
341
0.50
2.18
1.2
1.3
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
7
19
3.73
2.16
1.3
1.4
—
—
—
0
0
(4198724)
6
14
4.34
2.16
3.2
2.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
57
394
1.53
2.15
3.4
3.6
mmol/l
2.4
2.4
0.15
49
342
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
63
447
1.49
2.10
1.6
1.7
pmol/l
445.1
23947778.3
0.50
56
380
(3017143) Hepatitis C virus Ab [Presence] in Serum
48
321
1.57
2.09
2.0
1.6
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
150
1244
1.35
2.05
7.1
6.4
e9/l
0.0
0.0
0.00
128
1071
(3022096) Basophils/100 leukocytes in Blood
139
1140
1.35
2.05
7.4
6.4
%
0.7
0.7
0.08
130
1074
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
14
63
2.27
2.03
1.4
1.4
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
11
44
2.55
2.03
1.7
1.3
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
17
84
2.07
1.99
1.5
1.6
—
—
—
0
0
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
43
284
1.58
1.98
2.0
4.8
u/l
241.9
243.1
0.03
43
273
(3001604) Monocytes [#/volume] in Blood
149
1241
1.34
1.96
7.2
6.3
e9/l
0.6
0.6
0.01
127
1069
(3019198) Lymphocytes [#/volume] in Blood
154
1289
1.33
1.96
7.2
6.4
e9/l
1.7
1.9
1.39
132
1139
(3045683) HLA typing for celiac disease panel - Blood or Tissue
5
11
4.59
1.94
1.2
1.0
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
10
224
0.43
1.93
1.5
1.3
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
67
490
1.45
1.93
1.5
1.8
mg/l
1.2
1.3
0.35
42
372
(1002224) Polysomnography panel
15
72
2.13
1.89
1.3
1.0
—
—
—
0
0
(3022313) Gas panel - Capillary blood
17
86
2.02
1.88
5.7
6.0
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
8
28
2.90
1.87
2.4
2.7
mmol/l
2.1
1.6
—
8
28
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
18
94
1.96
1.83
1.6
1.8
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
141
1176
1.32
1.81
7.3
6.4
%
2.9
2.9
0.02
131
1108
(3013115) Eosinophils [#/volume] in Blood
153
1292
1.31
1.80
7.8
6.7
e9/l
0.2
0.2
0.78
131
1129
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
296
2744
1.40
1.80
20.4
11.2
mg/l
27.1
25.7
0.27
255
2056
(3037522) Nuclear Ab [Titer] in Serum
38
251
1.57
1.77
1.4
1.4
titre
337.8
280.0
—
9
58
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
6
18
3.37
1.75
1.0
1.2
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
146
1230
1.31
1.73
7.3
6.4
%
25.2
28.1
2.74
135
1157
(3013512) EKG study
87
679
1.37
1.73
3.6
3.3
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
25
149
1.73
1.71
1.1
1.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
54
388
1.46
1.71
2.5
2.4
e6/l
1.3
0.7
0.59
28
217
(3019069) Monocytes/100 leukocytes in Blood
141
1186
1.31
1.68
7.5
6.8
%
9.0
8.9
0.14
133
1123
(3044242) Glucose [Moles/volume] in Arterial blood
5
14
3.60
1.62
4.2
6.3
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
51
368
1.45
1.59
2.6
2.7
e6/l
5.3
1.7
0.70
27
199
(3012441) Differential panel - Pleural fluid
6
20
3.03
1.58
1.8
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
5
15
3.36
1.53
1.0
1.5
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
5
15
3.36
1.53
1.0
1.5
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
5
15
3.36
1.53
1.0
1.5
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
5
15
3.36
1.53
1.0
1.5
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
141
1205
1.28
1.45
7.4
6.2
%
59.2
56.7
1.77
131
1141
(4146454)
5
16
3.15
1.44
3.4
2.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
64
814
0.74
1.37
2.4
2.7
ug/l
0.7
0.7
0.07
45
493
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
42
301
1.45
1.37
11.3
5.8
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
32
218
1.51
1.33
1.7
1.6
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
78
623
1.32
1.33
3.3
2.8
ng/l
2027.2
1321.5
0.49
67
521
(40758558) Short blood count panel - Blood
77
614
1.32
1.33
7.3
7.7
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
136
1169
1.26
1.31
10.6
9.2
e9/l
0.0
0.0
0.18
109
960
(46235355) HIV 1 and 2 tests - Meaningful Use set
64
498
1.34
1.30
1.8
1.9
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
82
667
1.29
1.23
3.6
3.2
estimate
0.0
0.0
0.50
19
232
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
5
19
2.65
1.22
1.6
1.6
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
91
753
1.28
1.19
3.4
3.1
mmol/l
7.6
8.3
0.68
78
630
(3019150) Specific gravity of Urine by Refractometry
67
535
1.31
1.15
4.1
3.3
kg/l
1.0
1.0
0.03
12
70
(3021601) Nitrite [Presence] in Urine by Test strip
140
1223
1.23
1.15
4.7
4.2
estimate
0.0
0.0
0.00
24
242
(3023419) Bacteria identified in Sputum by Culture
7
31
2.28
1.11
2.0
2.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
272
2873
0.80
1.10
4.2
4.2
mmol/l
2.7
2.8
0.96
254
2641
(3022621) pH of Urine by Test strip
20
129
1.58
1.08
3.7
2.4
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
141
1241
1.22
1.06
3.5
3.0
estimate
0.0
0.0
0.00
23
228
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
42
317
1.37
1.05
1.9
2.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
5
22
2.29
1.03
1.8
1.3
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
5
22
2.29
1.03
2.0
1.9
—
489.5
—
0
6
(3021901) Oxygen saturation in Capillary blood
7
34
2.08
1.03
1.9
3.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
93
1087
0.81
1.01
3.3
3.8
%
22.6
21.3
0.30
38
491
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
7
35
2.02
1.00
1.3
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
5
23
2.19
0.98
1.0
1.6
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
5
23
2.19
0.98
2.2
1.4
—
—
—
0
0
(4306422)
5
23
2.19
0.98
1.0
1.1
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
26
183
1.45
0.97
1.7
3.5
e9/l
82.9
74.2
0.41
21
138
(40760892) CBC W Ordered Manual Differential panel - Blood
47
593
0.76
0.96
5.0
5.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
21
142
1.51
0.94
1.1
1.3
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
138
1228
1.20
0.91
3.5
3.0
estimate
0.0
0.0
0.00
23
235
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
16
103
1.58
0.89
1.3
1.2
—
32.7
—
0
7
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
63
518
1.26
0.88
1.3
1.3
u/ml
0.9
1.2
0.34
11
147
(3005988) Vibrio sp identified in Specimen by Organism specific culture
6
30
2.02
0.87
1.7
1.6
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
6
30
2.02
0.87
1.7
1.6
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
6
30
2.02
0.87
1.7
1.6
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
6
30
2.02
0.87
1.7
1.6
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
6
30
2.02
0.87
1.7
1.6
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
6
30
2.02
0.87
1.7
1.6
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
37
284
1.34
0.86
2.2
2.0
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
6
115
0.51
0.84
1.3
1.6
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
6
32
1.89
0.82
5.8
6.3
mg/l
11.4
10.4
—
6
32
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
16
106
1.53
0.80
2.1
2.5
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
26
0.00
0.78
0.0
1.7
—
—
—
0
0
(21494434) Karyotype in Bone marrow
0
28
0.00
0.76
0.0
1.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
24
2.10
0.75
1.0
1.1
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
13
84
1.57
0.73
1.5
1.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
62
730
0.82
0.72
3.5
2.7
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
120
1331
0.85
0.71
3.8
4.4
ug/l
7.8
2.2
0.45
101
1206
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
274
2616
1.18
0.71
15.9
10.6
ml/min/173m2
87.7
84.2
1.50
225
2100
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
15
101
1.51
0.71
1.7
2.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
5
26
1.94
0.71
1.0
1.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
18
127
1.44
0.69
2.1
2.1
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
9
59
1.54
0.69
1.4
1.2
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
5
27
1.86
0.68
1.0
1.4
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
5
27
1.86
0.68
1.0
1.4
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
5
27
1.86
0.68
1.0
1.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
18
129
1.42
0.64
1.8
2.9
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
49
408
1.23
0.64
1.6
1.5
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
5
29
1.73
0.64
1.4
1.2
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
263
2514
1.16
0.62
4.9
4.8
mmol/mol
38.8
39.2
0.25
248
2332
(3004775) Volume in Urine collected for unspecified duration
0
20
0.00
0.60
0.0
2.1
—
716.8
—
0
12
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
0
21
0.00
0.60
0.0
1.2
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(4062490)
0
22
0.00
0.59
0.0
1.4
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
0
22
0.00
0.59
0.0
1.4
—
0.4
—
0
14
(3027135) IgG subclass 1 [Mass/volume] in Serum
0
22
0.00
0.59
0.0
1.4
—
7.8
—
0
15
(3028192) IgG subclass 2 [Mass/volume] in Serum
0
22
0.00
0.59
0.0
1.4
—
3.0
—
0
15
(4035726)
18
241
0.73
0.59
1.3
1.4
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
8
53
1.52
0.58
1.0
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
6
35
1.73
0.58
1.2
1.2
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
10
65
1.55
0.56
1.4
2.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
9
60
1.51
0.54
1.0
1.2
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
9
63
1.44
0.52
3.1
4.1
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
9
64
1.42
0.52
1.1
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
13
92
1.43
0.51
1.2
1.4
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
13
93
1.41
0.49
1.2
1.2
—
—
—
0
0
(3044889) 12 lead EKG panel
198
1876
1.12
0.48
3.5
3.4
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
57
650
0.85
0.48
2.5
2.6
umol/l
333.6
6927.7
2.66
49
577
(40761511) CBC panel - Blood by Automated count
303
2946
1.16
0.48
18.5
10.3
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
7
47
1.50
0.48
1.6
2.4
g/l
0.0
0.0
—
7
42
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
24
296
0.80
0.45
1.3
1.4
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
7
50
1.41
0.45
1.6
2.4
g/l
0.0
0.1
—
7
45
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
7
51
1.38
0.44
1.1
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
27
221
1.24
0.43
4.4
3.0
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
10
70
1.44
0.42
1.1
1.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
8
58
1.39
0.42
1.0
1.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
26
314
0.81
0.41
1.3
1.2
u/ml
29.4
16.3
—
10
125
(3049717) Cytology report of Urine Cyto stain
14
105
1.35
0.41
2.4
2.6
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
37
431
0.84
0.41
1.7
1.4
—
—
—
0
0
(3000012) Reticulocyte production index
0
15
0.00
0.41
0.0
2.5
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
15
0.00
0.41
0.0
4.0
—
76.3
—
0
15
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
18
0.00
0.40
0.0
3.0
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
18
0.00
0.40
0.0
6.0
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
13
97
1.35
0.40
2.3
1.5
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
312
3051
1.15
0.39
10.5
8.8
u/l
29.4
28.5
0.31
306
2935
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
0
19
0.00
0.39
0.0
1.2
—
0.1
—
0
8
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
23
188
1.24
0.38
2.3
3.2
ml/min/173m2
80.0
70.9
—
7
76
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
12
89
1.36
0.38
1.8
1.8
u/l
40.8
36.7
0.19
12
82
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
9
68
1.33
0.38
1.6
1.3
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
5
37
1.36
0.37
1.2
1.5
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
23
189
1.23
0.37
1.4
2.9
g/l
11.4
10.6
0.47
23
176
(3022145) Colonoscopy Study observation
23
277
0.82
0.37
1.3
1.4
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
35
301
1.18
0.36
1.2
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
10
134
0.74
0.35
1.0
1.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
6
43
1.40
0.35
2.0
5.8
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
6
43
1.40
0.35
3.3
1.9
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
6
46
1.31
0.33
1.5
1.5
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
6
46
1.31
0.33
1.2
1.6
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
6
90
0.66
0.33
1.5
1.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
29
336
0.85
0.32
1.3
1.2
iu/ml
44.1
39.7
—
8
99
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
185
1774
1.09
0.32
3.1
2.9
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
7
52
1.35
0.31
2.0
2.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
7
53
1.33
0.31
1.0
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
7
54
1.30
0.30
1.3
1.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
8
106
0.75
0.29
1.4
1.5
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
8
67
1.20
0.26
1.1
1.6
—
—
—
0
0
(3000492) Spirometry study
24
277
0.86
0.26
1.1
1.4
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
5
74
0.67
0.26
1.0
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
5
75
0.66
0.26
1.0
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
5
75
0.66
0.26
1.0
1.2
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
68
732
0.91
0.25
3.9
3.7
mg/mmol
6.3
31.8
0.56
46
478
(3007164) IgA [Mass/volume] in Serum or Plasma
52
477
1.10
0.24
1.4
1.4
g/l
2.6
2.6
0.04
32
317
(3002523) Influenza virus A Ag [Presence] in Specimen
5
38
1.32
0.23
1.0
1.0
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
5
38
1.32
0.23
1.0
1.4
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
5
38
1.32
0.23
1.0
1.0
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
27
238
1.15
0.23
1.8
1.7
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
5
41
1.22
0.22
1.4
1.2
—
2.6
—
0
8
(3003694) ABO and Rh group [Type] in Blood
75
798
0.92
0.22
1.5
1.4
—
—
—
0
0
(3002256) Pathology report gross observation
28
314
0.88
0.21
1.2
1.3
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
5
42
1.19
0.21
1.4
2.6
u/ml
3.8
3.4
—
5
37
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(44806420)
0
11
0.00
0.21
0.0
2.8
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
2.1
—
2.8
—
0
5
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
10
0.00
0.21
0.0
1.3
—
7.9
—
0
10
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
2.0
—
211.9
—
0
10
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
12
98
1.23
0.21
1.0
1.3
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
8
102
0.78
0.21
1.6
1.5
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
8
105
0.76
0.21
1.8
4.4
u/ml
8.6
2429.1
—
8
93
(1617658) Protocol used for examination of sentinel lymph nodes
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
6
48
1.25
0.20
1.5
1.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3016750) Collection duration of Urine
0
14
0.00
0.20
0.0
2.6
—
537.6
—
0
9
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
6
49
1.23
0.20
1.3
1.6
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
14
165
0.84
0.20
1.9
3.3
e9/l
5.1
3.9
—
9
132
(3037756) Immunofixation for Serum or Plasma
6
50
1.20
0.20
1.0
2.0
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
6
51
1.18
0.19
2.7
5.5
—
—
—
0
0
(4010399)
18
156
1.16
0.19
1.4
1.4
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
17
195
0.87
0.18
3.1
5.7
%
0.0
0.2
—
6
62
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
21
236
0.88
0.17
1.7
1.4
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
22
196
1.13
0.17
2.2
5.4
%
1.0
0.5
—
5
60
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
11
92
1.20
0.16
1.8
1.7
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
10
119
0.84
0.15
3.3
3.1
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
9
78
1.16
0.15
2.3
2.5
—
—
—
0
0
(3008898) HLA-B27 [Presence]
7
87
0.80
0.14
1.0
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
264
2674
0.96
0.12
20.5
12.1
%
39.9
41.2
1.29
176
2035
(4034850)
10
86
1.17
0.11
6.8
6.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
17
154
1.11
0.10
1.1
1.2
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
5
44
1.14
0.10
1.6
3.6
e9/l
2.9
4.2
—
5
44
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
5
45
1.11
0.10
1.0
1.5
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
5
46
1.09
0.09
1.6
4.0
%
57.0
56.8
—
5
46
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
6
54
1.11
0.09
1.0
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
6
54
1.11
0.09
1.2
1.4
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
5
60
0.83
0.08
1.2
1.6
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
5
62
0.80
0.08
1.0
1.1
—
3.0
—
0
10
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
7
64
1.10
0.08
1.9
1.7
mg/l
9.1
12.4
—
7
59
(3004716) Salmonella sp identified in Stool by Organism specific culture
11
123
0.89
0.08
1.1
1.2
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
323
3247
0.96
0.07
27.4
16.5
e12/l
4.5
4.6
5.14
315
3133
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
73
712
1.03
0.06
1.6
1.6
mmol/l
1.5
1.4
0.54
63
598
(3007461) Platelets [#/volume] in Blood
323
3242
0.97
0.04
27.4
16.5
e9/l
250.8
243.1
1.19
316
3143
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
10
108
0.92
0.03
1.3
1.9
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
95
962
0.98
0.03
2.1
2.0
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
324
3249
0.98
0.02
27.4
16.5
e9/l
7.1
6.6
3.75
317
3137
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
267
2660
1.01
0.02
4.2
3.9
mmol/l
6.0
5.9
0.20
251
2418
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
98
988
0.99
0.01
4.0
3.0
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
21
216
0.97
0.00
2.8
5.4
%
1.0
0.7
—
8
77
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
27
264
1.02
0.00
1.8
1.7
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
16
158
1.01
0.00
1.3
1.5
g/l
0.8
1.7
1.39
16
144
(3012516) Albumin [Mass/volume] in Urine
68
677
1.01
0.00
3.2
3.0
mg/l
42.8
125.3
0.63
46
443
(3021440) Promyelocytes/100 leukocytes in Blood
21
206
1.02
0.00
2.8
5.6
%
0.0
0.1
—
8
70
(3024471) HLA-A [Type]
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3048879) Bone marrow aspiration report
0
9
0.00
0.00
0.0
3.0
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3027923) C peptide [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
2.4
—
1.1
—
0
9
(3024932) HLA-DR beta [Type]
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.8
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
0
8
0.00
0.00
0.0
3.9
—
42.5
—
0
8
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
6
0.00
0.00
0.0
6.8
—
—
—
0
0
(3010370) Gastrin [Moles/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.6
—
14.5
—
0
8
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3017115) Methotrexate [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
9.4
—
0.3
—
0
5
(3020393) Adenovirus Ag [Presence] in Stool
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
5
49
1.02
0.00
1.2
1.6
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
30.3
—
0
6
(3043410) Blood group antigens tested for on Red Blood Cells
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
4.3
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
6
0.00
0.00
0.0
6.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
5
52
0.96
0.00
1.6
1.7
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.2
—
0.3
—
0
6
(3022689) Creatine [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
5
50
1.00
0.00
1.0
2.0
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.7
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
0
7
0.00
0.00
0.0
3.7
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3011897) Casein IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: ST19_EPIDU_HAEMORRHAGE – Epidural haemorrhage
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).